Rosiglitazone
| Autor: | P.A. de Graeff, Eberhard Blind, E. Abadie, Kristina Dunder |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2011 |
| Předmět: |
medicine.medical_specialty
Combination therapy medicine.drug_class Endocrinology Diabetes and Metabolism Regulatory approval Type 2 diabetes Pharmacology Cardiovascular System Rosiglitazone EVENTS Diabetes mellitus Cardiovascular outcome studies European Medicines Agency Internal Medicine medicine Humans Hypoglycemic Agents Thiazolidinedione Summary of Product Characteristics Intensive care medicine Drug safety GLUCOSE CONTROL RISK Clinical Trials as Topic OUTCOMES Pioglitazone business.industry DEATH RECORD medicine.disease Cardiovascular risk Clinical trial MYOCARDIAL-INFARCTION Thiazolidinediones business CONSENSUS medicine.drug RECORD trial |
| Zdroj: | Diabetologia, 54(2), 213-218. SPRINGER |
| ISSN: | 0012-186X |
| Popis: | Abbreviations CHF Congestive heart failure CHMP Committee for Medicinal Products for Human Use EMA European Medicines Agency FDA Food and Drug Administration MAH Marketing authorisation holder PROactive Prospective Pioglitazone Clinical Trial in Macrovascular Events RECORD Rosiglitazone Evaluated for Cardiovascular Outcomes in Oral Agent Combination Therapy for Type 2 Diabetes SAG Scientific Advisory Group of the EMA SPC Summary of Product Characteristics TZD Thiazolidinedione |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink